Kuniko Horie

KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.

Kana Shibata, Rudolf Foglar, Kuniko Horie et al. · Molecular Pharmacology · 1995 · 230 citations

Use of recombinant α1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy

Rudolf Foglar, Katsushi Shibata, Kuniko Horie et al. · European Journal of Pharmacology Molecular Pharmacology · 1995 · 183 citations

Molecular Pharmacology, Prostatic Hypertrophy, Urology +12

Cloning, Functional Expression and Tissue Distribution of Human cDNA for the α1C-Adrenergic Receptor

Akira Hirasawa, Kuniko Horie, Toshihiro Tanaka et al. · Biochemical and Biophysical Research Communications · 1993 · 156 citations · Full text

Molecular Pharmacology, Signal Transduction, Molecular Physiology +12

Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor

Takashi Suzuki, Tomohiro Urano, Yasuhiro Miki et al. · Cancer Science · 2007 · 103 citations · Full text

Cloning, functional expression and tissue distribution of human <i>α</i>_1C‐adrenoceptor splice variants

Akira Hirasawa, Katsushi Shibata, Kuniko Horie et al. · FEBS Letters · 1995 · 93 citations · Full text